Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | AGER | Q15109 | 1/20 | 0.55 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | DHODH | Q02127 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30592857 | 1.00 | TDP1 (0.57) | TDP1KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL8686364 | 0.92 | P2RX7 (0.49) | TDP1KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL31182075 | 0.87 | TDP1 (0.52) | TDP1KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL949562 | 0.86 | TDP1 (0.50) | TDP1KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL31081770 | 0.85 | TDP1 (0.49) | TDP1KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL8427582 | 0.85 | TDP1 (0.49) | TDP1KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL7899073 | 0.84 | DHODH (0.56) | TDP1KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL6457226 | 0.83 | TDP1 (0.64) | TDP1ALDH1A1NPSR1MAPTHTT | |
| SCHEMBL5073283 | 0.83 | TDP1 (0.47) | TDP1KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL6609846 | 0.83 | TDP1 (0.47) | TDP1KDM4EALDH1A1NPSR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 601 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313835-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO., LTD. (KR) | 2025-10-09 | — | — | US | claimed |
| WO-2025149946-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO., LTD. (KR) | 2025-07-17 | — | — | WO | claimed |
| EP-4551193-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | Biorchestra Co., Ltd. (KR) | 2025-05-14 | — | — | EP | claimed |
| CN-119431432-A | Andrographolide diester derivative, preparation method and application | 西北农林科技大学 | 2025-02-14 | — | — | CN | claimed |
| CN-111295382-B | Bridged bicyclic compounds as farnesyl ester X receptor modulators | 百时美施贵宝公司 | 2024-02-02 | — | — | CN | claimed |
| WO-2024009268-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO., LTD. (KR) | 2024-01-11 | — | — | WO | claimed |
| CN-113912592-B | Honokiol dihydrofuran ester derivative, preparation method and application thereof | 西北农林科技大学 | 2023-03-10 | — | — | CN | claimed |
| CN-114436952-A | Synthesis method of 2-methoxy-3-amino-5-pyridine boronic acid pinacol ester and intermediate thereof | 杭州珠联医药科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-113912592-A | Honokiol dihydrofuran ester derivative, preparation method and application thereof | 西北农林科技大学 | 2022-01-11 | — | — | CN | claimed |
| EP-3568474-A1 | MODULATING EXPRESSION OF POLYPEPTIDES VIA NEW GENE SWITCH EXPRESSION SYSTEMS | Intrexon Corporation (US) | 2019-11-20 | — | — | EP | claimed |
| WO-2018132494-A1 | MODULATING EXPRESSION OF POLYPEPTIDES VIA NEW GENE SWITCH EXPRESSION SYSTEMS | INTREXON CORPORATION (US) | 2018-07-19 | — | — | WO | claimed |
| WO-2008013334-A1 | DEFORMYLASE INHIBITOR, PROCESS FOR THE PREPARATION THEREOF, AND COMPOSITION COMPRISING THE SAME | PROMEDITECH INC. (KR) | 2008-01-31 | — | — | WO | claimed |
| EP-1601642-A4 | BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX | RHEOGENE INC (US) | 2007-04-11 | — | — | EP | claimed |
| EP-1601642-A2 | BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX | RheoGene, Inc. (US) | 2005-12-07 | — | — | EP | claimed |
| WO-2004078924-A2 | BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX | RHEOGENE, INC. (US) | 2004-09-16 | — | — | WO | claimed |
| EP-0289180-B1 | METHOD OF CHLORINATION | PFIZER INC. (US) | 1992-12-02 | — | — | EP | claimed |
| EP-0289180-A2 | Method of chlorination | PFIZER INC. (US) | 1988-11-02 | — | — | EP | claimed |
| US-4716231-A | Chlorination of 2-methoxynicotinic acid | PFIZER INC. (US) | 1987-12-29 | — | — | US | claimed |
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-3879403-A | BENZENESULFONYLUREA DERIVATIVES | PFIZER | 1975-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | POLA1, SUB1, CTDSP1 | TDP1 21/4885KDM4E 4515/4885ALDH1A1 840/4885 |
| US-20250313835-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | HNRNPLL, UACA, POLRMT | TDP1 395/4885KDM4E 4318/4885ALDH1A1 4319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.